SG Americas Securities LLC Buys 8,152 Shares of HealthEquity, Inc. $HQY

SG Americas Securities LLC raised its stake in HealthEquity, Inc. (NASDAQ:HQY) by 178.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,715 shares of the company’s stock after purchasing an additional 8,152 shares during the quarter. SG Americas Securities LLC’s holdings in HealthEquity were worth $1,205,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the stock. Farther Finance Advisors LLC boosted its holdings in shares of HealthEquity by 232.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after buying an additional 172 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in HealthEquity during the second quarter worth $33,000. True Wealth Design LLC raised its position in HealthEquity by 3,522.2% during the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after acquiring an additional 317 shares in the last quarter. Cullen Frost Bankers Inc. lifted its stake in HealthEquity by 172.3% in the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after acquiring an additional 224 shares during the last quarter. Finally, Sellwood Investment Partners LLC bought a new position in shares of HealthEquity in the 2nd quarter valued at about $58,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on HQY. BMO Capital Markets reaffirmed a “market perform” rating on shares of HealthEquity in a report on Thursday, December 4th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $120.00 price target on shares of HealthEquity in a research report on Friday, December 5th. Wall Street Zen cut HealthEquity from a “buy” rating to a “hold” rating in a research report on Sunday, January 11th. Citigroup reiterated an “outperform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Finally, The Goldman Sachs Group cut HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price target on the stock. in a research note on Friday, January 9th. Two research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $119.60.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of the stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares in the company, valued at $4,366,073.90. This represents a 19.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. The trade was a 1.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 15,459 shares of company stock valued at $1,483,062 in the last three months. Insiders own 1.50% of the company’s stock.

HealthEquity Stock Performance

Shares of NASDAQ HQY opened at $85.37 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The firm has a market cap of $7.29 billion, a price-to-earnings ratio of 39.16, a P/E/G ratio of 1.23 and a beta of 0.20. The stock’s fifty day moving average price is $96.16 and its two-hundred day moving average price is $94.54. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company had revenue of $322.16 million during the quarter, compared to the consensus estimate of $320.92 million. During the same quarter last year, the firm earned $0.78 earnings per share. The company’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.